4 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Neovascular Macular Degeneration: new trials by email Literature Review of Neovascular Macular Degeneration trials Research Report on Neovascular Macular Degeneration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration Aflibercept - Neovascular Macular Degeneration | Phase 1 | Completed | University of Nebraska | 5 | 2014-09-05 | 2023-09-06 |
| Aflibercept in Polypoidal Choroidal Vasculopathy Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321), Visudyne - Neovascular Macular Degeneration | Phase 4 | Completed | Bayer | 333 | 2014-05-29 | 2020-12-02 |
| Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments ranibizumab - Age-related Macular Degeneration, Pigment Epithelial Detachment | Phase 2 / Phase 3 | Completed | Pacific Eye Associates | 15 | 2006-10-01 | 2012-04-12 |
| Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration Pegaptanib - Macular Degeneration, Age-related Macular Degeneration | Completed | Pfizer | 1001 | 2006-08-01 | 2011-01-13 |
Macular Degeneration (3) · Wet Macular Degeneration (2) · Neovascularization, Pathologic (1) · Retinal Detachment (1)
Eye Diseases (3) · Retinal Degeneration (3) · Retinal Diseases (3) · Metaplasia (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
aflibercept (2) · Ranibizumab (1) · Verteporfin (1) · pegaptanib (1)
Bayer (1) · Pacific Eye Associates (1) · Pfizer (1) · University of Nebraska (1)
United States (2) · Australia (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Japan (1) · Singapore (1) · South Korea (1) · Taiwan (1)
Anne Fung, MD (1) · Diana V Do, MD (1)